A 62-year-old heart attack patient surnamed Kim, who was hovering between life and death, received a coronary angioplasty to open blocked arteries to his heart in April 2009.The surgery was performed at the Seoul National University Hospital. At that time, his doctor asked Kim if he was willing to participate in a stem cell clinical test that was being promoted by the hospital, and he agreed. The surgery involved a procedure of injecting stem cells taken from his blood supply into the damaged heart muscle.
The operation ended after 30 minutes. After six months and two years, the stem cell clinical trial team conducted a magnetic resonance imaging scan of Kim’s heart. It was found to be improved, and it stayed improved during the following checkup period.
A team of professors at Seoul National University Hospital’s cardiovascular center, led by Kim Hyo-soo and Kang Hyun-jae, said yesterday that they requested the Committee for New Health Technology Assessment under the Ministry of Health and Welfare to approve the clinical use of their stem cell therapy in November of last year.
For full article see Joongang Daily.